Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
KPV: Limited clinical and preclinical evidence Mechanistic NF-B data Small clinical trials in IBD (oral) and atopic dermatitis (topical/oral) No published subcutaneous human data for systemic effects
The FDA has banned compounding and injection of peptides like GHK-Cu due to safety concerns
Supplementary Materials Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.
AbbVie, which paid $350 million to license a long-acting amylin analog from the firm Gubra, also recently announced Phase 1 data
Unique collection of proven ingredients Doctor guided formulations Frequently Asked Questions 1
See our full UK buyer's guide for Research Peptides
US$ 21.38
US$ 27.46
US$ 20.88
